Despite extensive epidemiological evidence of the health benefits of-3 polyunsaturated fatty acids (ω-3 PUFAs), clinical attempts of using ω-3 PUFAs to manage
Epoxyeicosatrienoic acids (EETs), the eicosanoids derived from arachidonic acid (AA) via the cytochrome P450 epoxygenase pathway, possess vasodilation, anti-inf
Oxidation-specific epitopes (OSE) are present on oxidized LDL, apoptotic cells, and modified proteins in the vessel wall and accumulate in response to hyperchol